VivoSim Labs, Inc. (VIVS)
0.2826
0.00 (0.00%)
USD |
NASDAQ |
Sep 14, 14:10
VivoSim Labs Debt to Equity Ratio : -0.1347 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.1347 |
| March 31, 2026 | -0.5141 |
| December 31, 2025 | 0.1828 |
| September 30, 2025 | 0.1489 |
| June 30, 2025 | 0.0862 |
| March 31, 2025 | 0.102 |
| December 31, 2024 | 3.618 |
| September 30, 2024 | 0.4234 |
| June 30, 2024 | 0.1929 |
| March 31, 2024 | 0.3871 |
| December 31, 2023 | 0.2428 |
| September 30, 2023 | 0.1897 |
| June 30, 2023 | 0.1448 |
| March 31, 2023 | 0.1178 |
| December 31, 2022 | 0.0853 |
| September 30, 2022 | 0.08 |
| June 30, 2022 | 0.0756 |
| March 31, 2022 | 0.0723 |
| December 31, 2021 | 0.0726 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.1485 |
| June 30, 2019 | 0.1334 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.0001 |
| December 31, 2014 | 0.0002 |
| September 30, 2014 | 0.0002 |
| June 30, 2014 | 0.0003 |
| March 31, 2014 | 0.0003 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Agenus, Inc. | -1.458 |
| Amgen, Inc. | 4.903 |
| Anika Therapeutics, Inc. | 0.1839 |
| BioCryst Pharmaceuticals, Inc. | -1.842 |
| Imunon, Inc. | 1.873 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 3.847M |
| Total Liabilities (Quarterly) | 6.193M |
| Shareholders Equity (Quarterly) | -2.346M |
| Current Ratio | 1.704 |
| Net Debt Paydown Yield | 4.41% |